Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Davalos M, Konno S, Eshghi M, Choudhury M
Roche is advancing an oral GLP-1 receptor agonist, CT-996, which it gained through its 2024 acquisition of Carmot Therapeutics, a Berkeley, California-based bio/pharmaceutical company, in a deal worth up to $3.1 billion ($2.7 billion at closing plus $400 million in potential milestone payments)
Sold for Research Use Only / Not FDA Regulated In Stock Order by 3 PM Central Time, ships today Select quantity to unlock savings
Namely, it is always applied alone (Sikiric et al., 1993
US$ 22.61
.webp)
US$ 28.02
US$ 26.82
